How Medical Practices Are Valued in Today’s Market

Medical practice valuation starts with one central question: what level of future cash flow can a buyer reasonably expect after the sale? The answer depends on the numbers, but also on the quality and transferability of the business. A practice with $1 million in adjusted earnings, multiple providers, documented systems, diversified payers, and stable patient demand will usually be valued more favorably than a practice with the same earnings that depends almost entirely on one retiring physician.

The most common valuation method for profitable medical practices is the market approach, using a multiple of adjusted EBITDA or seller’s discretionary earnings. EBITDA means earnings before interest, taxes, depreciation, and amortization. For larger practices, platforms, and institutional buyers, adjusted EBITDA is usually the key metric. For smaller owner-operated practices, seller’s discretionary earnings may be used because it reflects the total financial benefit available to an owner-operator.

Current U.S. market data shows a more disciplined valuation environment than the market saw several years ago. Healthcare services multiples remain attractive compared with many industries, but several market reports show compression from earlier highs. FocusBankers reported that median healthcare services EV/EBITDA multiples declined to roughly 11.5x in 2025 from 14.5x the prior year, with pricing dispersion between smaller add-on acquisitions and larger platform transactions. PwC also noted continued EBITDA multiple compression in parts of the health services market in early 2026, with deal activity more selective in certain subsectors.

For independent medical practices, practical valuation brackets often fall below broad healthcare services averages because many offices are smaller, owner-dependent, and less scalable than large healthcare platforms. As a general market guide, smaller medical practices often trade around 2.0x to 4.0x seller’s discretionary earnings, or roughly 3.0x to 6.0x adjusted EBITDA when EBITDA is the better metric. Mid-sized, well-managed practices with more than one provider, clean reporting, and stable growth may fall in the 5.0x to 8.0x EBITDA range. Larger specialty groups and platform-quality practices can command 8.0x to 12.0x or higher, depending on specialty, scale, growth, payer mix, and ancillary revenue. Some published 2026 market guides place smaller healthcare and medical practices around 3.0x to 7.0x EBITDA, with larger or more scalable organizations reaching 10.0x to 15.0x or more.

Specialty matters. Primary care practices are often valued differently from dermatology, ophthalmology, cardiology, orthopedics, gastroenterology, fertility, or women’s health practices. Specialty groups with procedure revenue, strong commercial payer mix, recurring demand, and ancillary services often receive stronger buyer attention. Recent physician practice M&A data shows platform transaction ranges by specialty can vary widely, including 8.0x to 12.0x for primary care platforms, 10.0x to 14.0x for gastroenterology, 12.0x to 15.0x for cardiology, and 14.0x to 20.0x for ophthalmology platforms. Add-on acquisitions are generally lower, often several turns below platform valuations.

Size also has a direct impact on value. A larger practice with management depth, multiple locations, multiple providers, and meaningful EBITDA is usually seen as less risky than a small practice where the owner is the main producer. Some market guidance indicates practices with $5 million or more in EBITDA may qualify as platform opportunities, which can attract meaningfully higher multiples than smaller add-on transactions.

Buyers also adjust value based on payer mix and revenue quality. A practice with strong commercial reimbursement, cash-pay services, low denials, and disciplined collections is usually more attractive than one with high write-offs, aging receivables, or heavy dependence on a single payer. Revenue is only valuable if it converts into predictable cash flow.

Provider dependency is another major valuation factor. If the selling physician produces most of the revenue and plans to leave soon after closing, the buyer must price in the risk of patient attrition, referral loss, and production decline. A longer transition period, associate providers, documented workflows, and team-based patient relationships can help protect value.

Industry standards also require normalization of earnings. This means adjusting the financials to reflect the true operating performance of the practice. Common adjustments may include owner compensation normalization, personal expenses run through the business, one-time legal or consulting costs, nonrecurring repairs, excess family payroll, above-market or below-market rent, and discretionary travel or auto expenses. These add-backs must be credible and documented. Aggressive or poorly supported add-backs can damage buyer trust and reduce offers.

Asset value is considered, but it rarely drives the entire valuation unless the practice is underperforming. Medical equipment, furniture, technology, and working capital may support value, but buyers are usually paying for cash flow, goodwill, patient relationships, and the ability to continue operations.

The best way to improve value is to prepare before going to market. Clean up financials, reduce owner dependency, strengthen provider contracts, document systems, improve collections, address compliance issues, review leases, and track patient and referral trends.

In today’s market, valuation is not just about applying a multiple. It is about proving that the earnings are real, stable, transferable, and worth paying for. The practices that earn the strongest valuations are the ones that give buyers confidence in the future, not just evidence of the past.